This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Abbvie Inc.. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Allan Olson: Innovator in Medical Treatments
Introduction
Allan Olson is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medical treatments, particularly in addressing diseases where interleukin-13 (IL-13) activity is detrimental. With a total of 3 patents, his work has the potential to impact many lives.
Latest Patents
Among his latest patents, Allan Olson has developed methods for treating diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies. This invention focuses on treating conditions such as eosinophilic esophagitis (EoE) and asthma. The methods involve administering a composition containing an interleukin-13 (IL-13) antibody or an antigen-binding fragment to a subject in need of treatment.
Career Highlights
Throughout his career, Allan has worked with prominent companies in the pharmaceutical industry, including AbbVie Inc. and AbbVie Manufacturing Management Unlimited Company. His experience in these organizations has allowed him to refine his expertise in medical innovations.
Collaborations
Allan Olson has collaborated with notable professionals in his field, including Gregg Timony and Sheila Gujrathi. These partnerships have contributed to the advancement of his research and inventions.
Conclusion
Allan Olson's work in developing treatments for diseases linked to IL-13 activity showcases his dedication to medical innovation. His patents and collaborations reflect his commitment to improving health outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile